Subcutaneous Abatacept in Renal Transplant Recipients
Condition: Kidney Transplant Recipient Intervention: Drug: Abatacept 125Mg/Ml Syringe Sponsors: Idelberto Badell; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abatacept | Allergy | Allergy & Immunology | Infectious Diseases | Orencia | Research | Transplant Surgery | Transplants | Urology & Nephrology